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Lipoprotein cholesterol is mobilized from lysosomes by actions of the NPC1 and NPC2 proteins. In this issue
of Cell Metabolism, Harrison et al. report on identification of an NPC2-interacting protein, the Nogo-B
receptor, that regulates NPC2 protein levels. NPC2 stabilization may represent a novel mechanism through
which cells respond to endocytosed cholesterol.In mammalian cells, cholesterol is essen-
tial for diverse cellular functions, such
as maintenance of membrane fluidity
and permeability, and serves as an essen-
tial precursor for bile acids, steroid
hormones, andbiologically activeoxygen-
ated cholesterol metabolites (Tabas,
2002). At the cellular level, cholesterol
requirements are met through de novo
synthesis and uptake of exogenous lipo-
protein cholesterol. Homeostatic regula-
tion of the cholesterol biosynthetic and
uptake pathways prevents accumulation
of excess free or unesterified cholesterol,
which is cytotoxic. Internalized lipoprotein
particles are trafficked to a late endosomal
compartmentwhere the cholesteryl esters
are hydrolyzed by acidic cholesteryl ester
hydrolase to free cholesterol (Brown and
Goldstein, 1983).Mobilization of the newly
hydrolyzed cholesterol from the endolyso-
somal compartment is mediated by the
Niemann-Pick type C1 (NPC1) protein,
which acts in concert with the NPC2, a
cholesterol-binding protein, to facilitate
egress of free cholesterol from the endoly-
sosome for delivery to subcellular pools
(Sturley et al., 2009). In this issue, Harrison
et al. present evidence for posttransla-
tional regulation of NPC2 protein levels
that may provide a mechanism for cells
to respond to influx of internalized lipopro-
tein cholesterol.
NPC2 is a soluble 132 amino acid
cholesterol-binding glycoprotein that is
mannose-6-P modified and is trafficked
from the trans-Golgi network to late
endosomes in a mannose-6-P receptor-
dependent manner (Naureckiene et al.,
2000). Although recent studies have
begun to elucidate its intralysosomal
cholesterol transfer function (Infante
et al., 2008), little is known of the mecha-
nisms that govern NPC2 protein matura-tion and stability. In the study by Harrison
et al., the authors identify NPC2 as
an interacting protein for the Nogo-B
receptor (NgBR) through a yeast two-
hybrid screen. Nogo-B belongs to the
reticulon superfamily and has been
implicated in chemotaxis and cell
morphogenesis in vitro (Acevedo et al.,
2004). The receptor for Nogo-B contains
a C-terminal domain that bears homology
to the cis-prenyltransferase (cis-IPTase)
family of lipid-modifying enzymes. These
enzymes bind isoprenyl lipids and cata-
lyze the condensation of isopentenyl
diphosphate to form long-chain poly-
prenyl diphosphates. This domain in
NgBR, however, lacks the cis-IPTase
activity (Miao et al., 2006). Curiously,
the only other known mammalian pro-
tein with a cis-IPTase domain, human
dehydrodolichyl diphosphate synthase
(DHDDS), was previously reported to
interact with NPC2 (Kharel et al., 2004).
The functional relevance of either of these
NPC2 interactions is uncertain, asNPC2 is
not known to be a prenylated protein. On
theother hand,NPC2undergoesN-glyco-
syation, which involves formation of poly-
prenyl and dolichol intermediates, raising
the possibility that NgBR and DHDDS
may serve as scaffolds within the ER
for binding nascent glycoproteins or as
sensors for lipid-modified proteins.
The present study provides compelling
evidence that NgBR and, specifically, the
C-terminal cis-IPTase domain regulate
NPC2 protein levels. Whereas overex-
pression of NgBR prolongs the half-life
of NPC2, siRNA-mediated knockdown of
NgBR markedly reduces NPC2 protein
levels, phenocopying the cholesterol
homeostatic defects in NPC2-deficient
cells. Determination of the subcellular
compartment in which these proteinsCell Metabolism 10,interact is central to understanding the
physiological relevance of the NPC2-
NgBR interaction. Based on subcellular
fractionation and evidence of ER retention
of NPC2 in NgBR-overexpressing cells,
the authors conclude that NPC2 and
NgBR likely interact within the ER,
perhaps during NPC2 synthesis. It is
possible, however, that NgBR may have
a life outside of the ER. Previous studies
from Sessa and colleagues indicated
that NgBR resides at the cell surface
as a receptor for Nogo-B (Miao et al.,
2006), and both immunofluorescence
and subcellular fraction data from the
current study suggest that a portion of
NgBR may be lysosomal. Consistent
with this interpretation, NPC2 protein
levels are augmented in NgBR knock-
down cells incubated with exogenous
NPC2. Because uptake of extracellular
NPC2 protein and subsequent sorting to
the lysosome is ER independent, these
findings raise the intriguing possibility
that NgBR regulates intralysosomal
stability of NPC2.
To sort out these possibilities, a key
experiment will be to perform metabolic
labeling of NPC2 and to examine the
effect of NgBR expression/knockdown
on the ER-to-Golgi transit of NPC2
protein. If NgBR regulates NPC2 stability
at the level of the ER, then knockdown
of NgBR, for example, would be expected
to reduce the rate of maturation of NPC2
from endoglysidase-H-sensitive (i.e., ER
localized) to endoglysidase-H-resistant
(i.e., post-ER compartment localized)
species. On the other hand, regulation
at the level of the lysosome would not
affect procession of NPC2 thorough the
secretory pathway but would affect the
half-life of endoglysidase-H-resistant (e.g.,
lysosomal) species. Further insight intoSeptember 2, 2009 ª2009 Elsevier Inc. 161
Cell Metabolism
Previewsthe nature of the NPC2-NgBR interaction
will come from the metabolic labeling
studies, coupled with examination of the
mode of NPC2 degradation. Such studies
will establish whether, in the absence of
NgBR, NPC2 is degraded within the ER
or is targeted for proteosomal degrada-
tion from the lysosome. Because NPC2-
mediated sterol transfer in vitro does not
require NgBR (Cheruku et al., 2006;
Infante et al., 2008), NgBRmay principally
exert its effect by retaining sufficient
levels of NPC2 protein, which one could
hypothesize may be rate limiting, to facil-
itate rapid intralysosomal transfer of lipo-
protein-derived cholesterol from internal
membranes to NPC1 at the limiting lyso-
somal membrane.
The NPC1-NPC2 pathway acts as
a critical checkpoint for sensing the flux
of lipoprotein-derived cholesterol through
endocytic pathway. This is achieved
through delivery of free cholesterol to the
ER sterol-sensing machinery and by
promoting synthesis of side-chain oxy-
sterols, which act cooperatively with ER
membrane cholesterol to downregulate
cholesterol synthesis and uptake (Frolov
et al., 2003). Regulation of NPC2 protein
levels by NgBR would potentially offer
an additional point of regulation to the
diverse transcriptional and posttransla-Bile Acids Have th
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Despite the obvious advantage of in-
creased exercise and restricted calorie
intake and the availability of treatments
that target obesity and associated disor-
ders, the worldwide fat epidemic con-
tinues unabated. Recent studies sug-
162 Cell Metabolism 10, September 2, 2009tional regulatory pathways that contribute
to maintenance of cellular cholesterol
balance. In this event, it would be ex-
pected that NgBR protein levels might
be subject to sterol regulation, perhaps
at the level of protein expression or even
subcellular localization.
The study by Harrison et al. under-
scores the power of unbiased genetic
screens. In future studies, investigation
of the specificity and nature of the
NPC2-NgBR binding will shed light onto
the physiological relevance of this unan-
ticipated protein interaction. It will be
instructive to define the regions of NPC2
necessary to support NgBR binding and
whether glycosylation-deficient forms of
NPC2 (i.e., Asn-39 and Asn-116 mutants)
permit binding to NgBR. A critical
question is whether the stabilizing effect
of NgBR is specific for NPC2 or more
broadly extends to other prenlyated or
N-glycosylated proteins. If NgBR ulti-
mately is shown to regulate NPC2
protein levels in a specific and possibly
sterol-regulated fashion, then the NgBR-
NPC2 interaction may serve as a molec-
ular rheostat that responds to the magni-
tude of lipoprotein cholesterol flux
through the endocytic pathway. Thus,
regulation of NPC2 protein stability would
appear to provide yet another layer ofe Gall to Function
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mas et al. (2009) show that specific a
proves pancreatic and hepatic funct
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gest that the development of bile acid
mimetics may prove useful in the treat-
ment of obesity-related disorders. In a
tour de force published in this issue of
Cell Metabolism, Thomas et al. (2009)
demonstrate that activation of TGR5 pro-
ª2009 Elsevier Inc.control to limit free cholesterol-mediated
cytotoxicity.
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vides significant protection from many
physiological changes that normally arise
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This is the latest in a series of unex-
pected findings that have expanded the
role of bile acids from simple detergents
